Shortage of key COVID drug remdesivir fuels illegal trade in India
The U.S. government's deal to buy up most of the world's remdesivir has left many countries short, forcing families to pay up to 10 times the market price, if they can.
Remdesivir
Studies clarify what drugs work — and don't — for COVID-19
More formal studies provide a better understanding of how to treat COVID-19.
Remdesivir shortages force docs into "heart-wrenching" choices
Physicians say federal rules for distributing the COVID-19 drug are unclear, leaving some hospitals in the lurch.
AdventHealth CEO: Florida COVID cases likely to peak in July
Terry Shaw says his hospital system is well-equipped with PPE, staff and key medications, including remdesivir, to care for patients.
Coronavirus rips through the South
The South is facing a dire situation, as coronavirus cases across the country hit a record high. Janet Shamlian reports.
COVID drug remdesivir comes at a cost
A five-day treatment of remdesivir, one of two known drugs proven to help treat COVID-19, will cost $3,120 for a typical U.S. patient with commercial insurance. Gilead Sciences, the drugmaker, has promised a lower “government price,” but that excludes Medicare and Medicaid. Dr. Shoshana Ungerleider joined CBSN to discuss the potential impact.
Gilead's remdesivir will cost $3,120 for private insurance
COVID-19 treatment's price will depend on whether private insurers or government programs like Medicaid are paying.
Staying safe as states see spike in COVID-19
More than a dozen states across the U.S. are seeing an increase in confirmed coronavirus cases, and some are reporting record spikes. Dr. Bob Lahita joined CBSN to discuss how we can stay safe as states open up.
U.S. supply of remdesivir could run out within weeks, top official warns
The drug, manufactured by Gilead, was found to have shortened the recovery time for hospitalized coronavirus patients.
Emory University's groundbreaking COVID-19 vaccine trial
As the drug remdesivir has been shown to modestly shorten recovery time from the coronavirus, researchers at Emory University Hospital in Atlanta are adding even more fire power to the battle against the virus. Dr. Jon LaPook takes a look.
Researchers combining remdesivir with other drugs to better fight virus
"What the remdesivir does is it stops the spark — and the immune modulator will hopefully be putting ash or putting dirt on the fire to put it out," one doctor said.
Potential COVID-19 treatment enters new testing phase
The National Institutes of Health say researchers have begun testing a potential coronavirus vaccine. Meanwhile, another blend of drugs designed to fight COVID-19 has entered a new phase. Dr. Jon LaPook has the latest in CBS News' "Racing to a Cure" series.
White House touts possible COVID treatment
A drug that may shorten the recovery time of hospitalized coronavirus patients is being hailed as a potential breakthrough in the fight against the pandemic. Dr. Anthony Fauci lauded the drug remdesivir's "positive effect in diminishing the time to recovery" for patients in a clinical trial. While the drug is not yet approved, President Trump urged the FDA to get through the process as soon as possible. Ben Tracy reports from the White House, where daily task force briefings have been replaced with economy-focused events.
Remdesivir shows promise as COVID treatment
An experimental drug is showing promise in treating the coronavirus. Preliminary results from a clinical trial carried out by the National Institutes of Health found patients taking remdesivir recovered an average of four days sooner than those on a placebo. The FDA may now consider an emergency approval to allow for broad use of the drug, though the findings still need to be peer-reviewed. Dr. Tara Narula spoke to a patient in that study, and a scientist fighting to get more answers.
Agus on remdesivir & COVID-19 vaccine trial
Dr. David Agus on potential breakthroughs in the race for treatments for the coronavirus. A clinical trial shows the antiviral drug, remdesivir, shortens the recovery time of hospitalized COVID-19 patients. And Oxford University scientists think they may have a vaccine by September.
Protests intensify as dozens of states ease restrictions
Protests erupted in Chicago over stay-at-home orders. Similar frustration is boiling over in Charlotte, North Carolina. Janet Shamlian reports.
Search for a COVID-19 treatment or vaccine
In the race to find a cure for COVID-19, doctors are looking at treatments for HIV patients. Dr. Stephen Parodi, national infectious disease leader for Kaiser Permanente, explains to CBSN's Reena Ninan why those medications stand out, why the antiviral drug remdesivir matters, and what to expect this flu season.
New antibody test claims higher accuracy
The FDA has granted emergency authorization for a coronavirus antibody test from Roche that claims to be 100% accurate in finding antibodies in blood and 99.8% accurate in detecting the lack of antibodies. Dr. Shoshana Ungerleider joined CBSN to discuss that plus other developments in fighting the pandemic.
Gilead CEO says remdesivir could reach patients within days
Daniel O'Day says the drug will soon be deployed to the "most urgent" patients following the drug's emergency use authorization Friday.
Gilead CEO says remdesivir could reach COVID-19 patients within days
Daniel O'Day said on "Face the Nation" that Gilead has donated its entire supply of remdesivir to be administered to hospitalized COVID-19 patients.
Face The Nation: O'Day, Bostic, Kelly
Missed the second half of the show? The latest on the coronavirus vaccine remdesivir, the future on air travels, coronavirus job losses and the latest sexual assault allegations against Joe Biden.
Transcript: Gilead CEO Daniel O'Day on "Face the Nation"
The following is a transcript of an interview with Gilead Sciences CEO Daniel O'Day that aired Sunday, May 3, 2020, on "Face the Nation."
Dr. Jon LaPook: This is not the time to abandon science
While Remdesivir is seen as a step forward in treating COVID-19, we are still far from a cure or vaccine
FDA authorizes remdesivir for emergency use as coronavirus treatment
The drug, produced by Gilead Sciences, may shorten the time it takes seriously ill patients to recover from COVID-19.
Gilead's coronavirus drug remdesivir: Here's what to know
Hopes are high for antiviral drug after a clinical trial showed promise, but the benefits may be limited, experts say.
Trump says he'll start paying for ads after pushback over taxpayer funding
Jim Bakker, who co-founded "The PTL Club" but fell into disgrace, dies at 86
Trump suggests letting Iran "take out" LA, San Diego during rally
Rubio calls on Russia to be more open about plague lab worker's death
Live
Iran's Houthi allies deny losing ground as Mideast crisis engulfs Yemen
Ex-"American Idol" contestant Caleb Flynn gets life sentence
Alleged Chinese agent makes federal court appearance
Only On CBS
Takeaways from Alito's CBS News interview
